The pharmaceutical injectable manufacturing sector is experiencing unprecedented transformation through lean manufacturing adoption. This analysis examines current implementation trends, productivity impacts, and quality integration strategies based on data from leading pharmaceutical organizations.
- Accelerating NAMs For A Human-Based Future In CGT Development
- The Rise Of NAMs
- Navigating The Complexities Of NK Cell Therapy Development
- FDA Priority Voucher Program Submissions Window Opens On New Website
- 5 Cs For Responding To FDA-483s — Strategies For Effective Compliance And Resolution
- Outsourced, In-House, Or A Combo: An Agile Recruiting Strategy Fuels Growth In Pharmas And Biotechs
- 5 Best Practices For Improving AI Literacy In A GxP Environment
- AI Data Security: The 83% Compliance Gap Facing Pharmaceutical Companies
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Achieving Optimal CAR-T Cell Generation
Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.
-
AAV Empty/Full Ratio Assessment Using The Octet® AAVX Biosensors
Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.
-
Exploring Perfusion Technology For Virus Manufacturing Process Intensification
Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.
-
Harnessing The Versatility Of Magnetic Beads In CAR T Cell Manufacturing
Explore advanced magnetic bead-based methods for isolating T cells, enabling high efficiency, scalability, and viability in CAR T cell manufacturing while addressing challenges posed by diverse patient samples.
-
Developing A HIC Polishing Step For The Removal Of mAb Aggregates
Learn in-depth about the development of a flow-through polishing step that employs hydrophobic interaction chromatography for the elimination of monoclonal antibody aggregates.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Electroporation Enables Efficient Antibody Discovery By Mammalian Display
Therapeutic antibody developers leverage mammalian display to identify promising candidates. Electroporation enables superior sequence diversity, enhanced library coverage, and streamlined workflows.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
Cervical Cancer - Global Clinical Trial Landscape (2024)
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
-
Cell Cube System For Serum-Free Culture Of Vero Cells
Review our work to establish a protocol for culturing Vero cells in serum-free medium on the Corning CellCube System, a compact and scalable method for mass culture of attachment-dependent cells.
NEWSLETTER ARCHIVE
- 08.01.25 -- Biopharma Needs A Boost — Our Newest Podcast Has Ideas
- 08.01.25 -- Redefining CGT With Exosomes And EVs
- 07.31.25 -- Is Your Pharma Facility Ready For The Next Public Health Crisis?
- 07.30.25 -- Audit Trail Compliance And What To Look For In Mitigation Software
- 07.29.25 -- STREAM Edition: Path To IND: AAV Transient Transfection, Producer Cell Line Platforms

- Accelerating NAMs For A Human-Based Future In CGT Development
- Navigating The Complexities Of NK Cell Therapy Development
- Redefining CGT With Exosomes And EVs
- Inside AviadoBio And Astellas's Shared Mission To Bring Gene Therapy To Patients With FTD-GRN
- Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More
CELL AND GENE CONTENT COLLECTIONS

While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections